T‐cell expansions in patients with multiple myeloma have a phenotype of cytotoxic T cells

The presence of T‐cell clones in peripheral blood has been previously shown to be associated with a survival advantage in patients with multiple myeloma and suggests that the expanded T‐cell populations may be involved in an anti‐tumour response. We studied the T‐cell receptor (TCR) repertoire of 38 patients with myeloma to identify and characterize the expanded T‐cell populations by flow cytometry. T‐cell expansions were found in 79% of the patients. The expansions occurred randomly among the 21 variable regions of the TCR β chain (Vβ) studied, representing 62% of the V‐β repertoire, and were stable during an 18‐month follow‐up. The phenotype of the expanded V‐β populations was predominantly CD8+, CD57+, CD28− and perforin+, which differed significantly from the other non‐expanded Vβ populations. The expression of the apoptosis markers Fas (CD95) and bcl‐2 were similar between the expanded and non‐expanded Vβ populations. In conclusion, expanded T‐cell populations were frequent in patients with myeloma, they remained unchanged during follow‐up and had phenotypic characteristics of cytotoxic T cells. These data add further support to the concept that the T‐cell expansions may have an immunoregulatory role in myeloma.

[1]  Mugnaini,et al.  The T cell receptor repertoire of CD8+CD28− T lymphocytes is dominated by expanded clones that persist over time , 1999, Clinical and experimental immunology.

[2]  Frassanito,et al.  CD8+/CD57+ cells and apoptosis suppress T‐cell functions in multiple myeloma , 1998, British journal of haematology.

[3]  A. Cmelak,et al.  Long-term depletion of naive T cells in patients treated for Hodgkin's disease. , 1997, Blood.

[4]  E. Halapi,et al.  T cell repertoire in patients with multiple myeloma and monoclonal gammopathy of undetermined significance: Clonal CD8+ T cell expansions are found preferentially in patients with a low tumor burden , 1997, European journal of immunology.

[5]  D. Joshua,et al.  The prognostic significance of T cell receptor β gene rearrangements and idiotype-reactive T cells in multiple myeloma , 1997, Leukemia.

[6]  P. Kourilsky,et al.  Expanded CD4+ and CD8+ T cell clones in elderly humans. , 1997, Journal of immunology.

[7]  N. Munshi.  Immunoregulatory mechanisms in multiple myeloma. , 1997, Hematology/oncology clinics of North America.

[8]  Q. Yi,et al.  Idiotype‐specific T lymphocytes in monoclonal gammopathies: evidence for the presence of CD4+ and CD8+ subsets , 1997, British journal of haematology.

[9]  C. Franceschi,et al.  Expansion of cytotoxic CD8+ CD28− T cells in healthy ageing people, including centenarians , 1996, Immunology.

[10]  J. Gribben,et al.  B7-mediated costimulation and the immune response. , 1996, Blood reviews.

[11]  H. Ostrer,et al.  Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. , 1996, Journal of immunology.

[12]  J. Melenhorst,et al.  Persistent clonal excess and skewed T-cell repertoire in T cells from patients with hairy cell leukemia. , 1996, Blood.

[13]  P. Moss,et al.  Clonal populations of CD4+ and CD8+ T cells in patients with multiple myeloma and paraproteinemia. , 1996, Blood.

[14]  P. Lehner,et al.  CD8highCD57+ T lymphocytes in normal, healthy individuals are oligoclonal and respond to human cytomegalovirus. , 1995, Journal of immunology.

[15]  J. Ceuppens,et al.  Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down‐regulation on CD8+ T cells from HIV‐infected subjects , 1995, Clinical and experimental immunology.

[16]  P. Gregersen,et al.  Oligoclonal CD8+ T cells are preferentially expanded in the CD57+ subset. , 1995, Journal of immunology.

[17]  A. Wargnier,et al.  Cord blood T lymphocytes lack constitutive perforin expression in contrast to adult peripheral blood T lymphocytes. , 1995, Blood.

[18]  F. Orlanducci,et al.  T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions. , 1994, Journal of immunology.

[19]  H Hengartner,et al.  Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. , 1994, Science.

[20]  J. Matthews,et al.  Peripheral blood lymphocyte surface antigen expression and prognosis in myeloma: Australian Leukaemia Study Group Study. , 1994, Leukemia & lymphoma.

[21]  A. Boylston,et al.  The human T cell antigen receptor repertoire: skewed use of Vβ gene families by CD8+ cells , 1994, Clinical and experimental immunology.

[22]  D N Posnett,et al.  Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy" [published erratum appears in J Exp Med 1994 Mar 1;179(3):1077] , 1994, The Journal of experimental medicine.

[23]  W. Strober,et al.  Functional abnormalities of CD8+ T cells define a unique subset of patients with common variable immunodeficiency. , 1993, Blood.

[24]  T. Rème,et al.  Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease. , 1993, Arthritis and rheumatism.

[25]  L. Lanier,et al.  CD28- T lymphocytes. Antigenic and functional properties. , 1993, Journal of immunology.

[26]  B. Autran,et al.  A soluble factor released by CD8+CD57+ lymphocytes from bone marrow transplanted patients inhibits cell-mediated cytolysis. , 1991, Blood.

[27]  J. Grunewald,et al.  Predominant T cell receptor V gene usage in patients with abnormal clones of B cells. , 1991, Blood.

[28]  C. Katlama,et al.  A lectin‐binding soluble factor released by CD8+CD57+ lymphocytes from AIDS patients inhibits T cell cytotoxicity , 1991, European journal of immunology.

[29]  M. Boccadoro,et al.  Multiple myeloma: increased circulating lymphocytes carrying plasma cell-associated antigens as an indicator of poor survival. , 1990, Blood.

[30]  H. Mellstedt,et al.  Presence of clonal T cell populations in chronic B lymphocytic leukemia and smoldering myeloma , 1990, The Journal of experimental medicine.

[31]  B. Autran,et al.  Cell-mediated suppression of HIV-specific cytotoxic T lymphocytes. , 1989, Journal of immunology.

[32]  W. Vainchenker,et al.  In vitro inhibition of normal human hematopoiesis by marrow CD3+, CD8+, HLA-DR+, HNK1+ lymphocytes. , 1988, Blood.

[33]  A. Palumbo,et al.  Activated idiotype-reactive cells in suppressor/cytotoxic subpopulations of monoclonal gammopathies: correlation with diagnosis and disease status. , 1988, Blood.

[34]  J. Farcet,et al.  Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantation. , 1986, Journal of immunology.

[35]  A. Gratwohl,et al.  The effect of cytomegalovirus infection on T lymphocytes after allogeneic bone marrow transplantation. , 1985, Clinical and experimental immunology.

[36]  C. Legendre,et al.  Two-color immunofluorescence and flow cytometry analysis of lymphocytes in long-term renal allotransplant recipients: identification of a major Leu-7+/Leu-3+ subpopulation. , 1985, Journal of immunology.

[37]  C. Grossi,et al.  Morphologic and phenotypic features of the subpopulation of Leu-2+ cells that suppresses B cell differentiation. , 1984, Journal of immunology.

[38]  A. Landay,et al.  Characterization of a phenotypically distinct subpopulation of Leu-2+ cells that suppresses T cell proliferative responses. , 1983, Journal of immunology.

[39]  M. Mackenzie,et al.  Studies on the pathogenesis of an immune defect in multiple myeloma. , 1977, The Journal of clinical investigation.

[40]  S. Salmon,et al.  A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.

[41]  M. Oken,et al.  Altered T cell repertoire usage in CD4 and CD8 subsets of multiple myeloma patients, a Study of the Eastern Cooperative Oncology Group (E9487). , 1999, Leukemia & lymphoma.